At CRK Clinical Research Key, we offer expert guidance in Biosimilar and generic development in Kenya, ensuring cost-effective and efficient pathways to high-quality, safe, and effective clinical studies at every stage.
Comprehensive Biosimilar & Generics Development Support
Suppose you aim to develop cost-effective alternatives to existing biological drugs (Biosimilars) or small-molecule drugs (Generics). In that case, CRK provides comprehensive support and a wide range of expert biosimilar and generic solutions. Our team will craft a tailored strategy to mitigate risks and ensure a smooth, cost-efficient clinical development process for your product.
Expertise in Global Biosimilar Clinical Plans
We specialize in designing and executing global biosimilar clinical strategies, ensuring timely delivery and high-quality results. Our key services include:
✔ Gap analysis for comparative analytical similarity assessments
✔ Drug development consulting
✔ Strategic advisory for biosimilar & generic development
Enhancing Efficiency & Reducing Risk
We provide:
- Clinical pharmacology expertise
- Bioanalytical laboratory services
- Operational support for product authorization
All our solutions are designed to streamline processes, enhance efficiency, reduce costs, and minimize risks in biosimilar and generic development.
Key Services
- Create and execute global biosimilar clinical strategies
- Ensure timely delivery and high-quality outcomes
- Conduct gap analysis for analytical similarity testing
- Provide drug development consulting and strategic advice
- Offer clinical pharmacology expertise
- Support for Pharmacokinetics and Pharmacodynamics (PKPD)
- Deliver flexible services to enhance efficiency
- Bioanalytical laboratory testing
- Consulting support for product authorization
